Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 63629-9187 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
Figure 2 - duloxetine 03
The figure shows the proportion of patients with relapse over time in days from randomization in a clinical trial comparing a placebo to duloxetine delayed-release capsules. As time passes, a higher proportion of patients in the placebo group relapse compared to those in the duloxetine group.*
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 5 - duloxetine 06
The text seems to be a chart that shows the percentage of improvement in pain from baseline among patients who received either DUL 50mg once daily, DUL 50mg twice daily, or a placebo. It does not provide specific numerical values for the percentage of improvement.*
Figure 6 - duloxetine 07
Figure 8 - duloxetine 08
The text displays a chart comparing the percentage of patients with improved pain levels in a placebo group versus a group treated with DUL 60/120 mg once daily. The chart shows that 80% of patients treated with DUL showed improvement compared to 70% of the placebo group. The x-axis displays percentage levels of improvement from 0% to 100%.*
Figure 9 - duloxetine 09
This text shows a chart displaying the percentage of patients who improved their pain levels after taking either a placebo or DUL 60 mg once daily. The chart also represents the percent improvement in pain from baseline in a BOCF analysis.*
Figure 10 - duloxetine 10
The graph shows the percentage of patients improved in terms of pain management. The x-axis represents the percent improvement in pain from baseline, and the y-axis displays the different treatments. The placebo treatment displayed no improvement in pain management, while the faga - DULB0/120 mg once daily treatment had a 100% improvement in pain management. The numbers on the x-axis range from 0 to 290.*
Label - lbl636299187
This is a prescription medication named Duloxetine Hydrochloride USP, containing 40 mg Duloxetine per capsule. The package contains 30 capsules that should be stored at 25°C and away from children. It is recommended to read the accompanying literature for dosage information and the medication guide should be dispensed to each patient. The NDC number is 63629-9187-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.